TMEM43 and breast cancer: Considering changes in RIF1 splice variant expression in the different breast cancer subtypes, we found that LumA, LumB, and HER2E breast cancers showed a significantly decreased proportion of RIF1-L transcript (Figure 2B), in line with our observation for all breast cancer subtypes combined (Figure 1F).